Tag: MATT DOLAN

Oura Health has secured a $75 million Series D investment from Dexcom, enhancing its valuation to over $5 billion. The partnership aims to integrate data between Oura’s health app and Dexcom’s glucose monitoring platform, set to launch in 2025, empowering users with personalized insights into metabolic health. Oura reports significant user interest in dietary impacts…